Global Organ Preservation Market 2023-2027
The organ preservation market is forecasted to grow by USD 106.96 million during 2022-2027, accelerating at a CAGR of 6.91% during the forecast period. The report on the organ preservation market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.
The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by growing demand for organ transplants, advancements in preservation techniques, and increasing awareness of organ donation and donor programs.
Technavio's organ preservation market is segmented as below:
- By Type
- Living organ donation
- Deceased organ donation
- By End-user
- Hospitals and clinics
- Organ banks
- Others
- By Geographical Landscape
- North America
- Europe
- Asia
- Rest of World (ROW)
This study identifies the increasing prominence of normothermic perfusion systems as one of the prime reasons driving the organ preservation market growth during the next few years. Also, integration of machine learning and AI and advances in bioengineering and 3D printing will lead to sizable demand in the market.
The report on the organ preservation market covers the following areas:
- Organ preservation market sizing
- Organ preservation market forecast
- Organ preservation market industry analysis
The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading organ preservation market vendors that include 21st Century Medicine, Accord Healthcare Ltd., Biochefa Pharmaceutical Research And Production Plant Ltd., BioLife Solutions Inc., Bridge to Life Ltd., Carnamedica, dr. Franz Koehler Chemie GmbH, EBERS MEDICAL TECHNOLOGY SL, Global Transplant Solutions, Organ Recovery Systems Inc., OrganOx Ltd., Paragonix Technologies Inc., Preservation Solution Inc., Revive Organtech Inc., SALF SpA, Stellantis NV, TransMedics Inc., TX Innovations, Waters Medical Systems LLC , and XVIVO Perfusion AB. Also, the organ preservation market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.
The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.
The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.